Hikma Pharmaceuticals buy BNP Paribas
Start price
14.05.25
/
50%
€23.40
Target price
14.05.26
-
Performance (%)
-0.85%
Price
15.07.25
€23.00
Summary
This prediction is currently active. Since the start of the prediction for Hikma Pharmaceuticals the price has only changed by -0.85%. This prediction currently runs until 14.05.26. The prediction end date can be changed by BNP_Paribas at any time. BNP_Paribas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hikma Pharmaceuticals | -0.870% | -0.870% |
| iShares Core DAX® | -0.727% | 2.783% |
| iShares Nasdaq 100 | 1.839% | 5.294% |
| iShares Nikkei 225® | -2.033% | -0.196% |
| iShares S&P 500 | 1.334% | 4.044% |
Comments by BNP_Paribas for this prediction
In the thread Hikma Pharmaceuticals diskutieren
Hikma Pharmaceuticals PLC (OTCMKTS: HKMPF) is now covered by analysts at BNP Paribas. They set an "outperform" rating on the stock.
Ratings data for HKMPF provided by MarketBeat